Literature DB >> 24804754

Detecting cancer by monitoring circulating tumor DNA.

Paul T Spellman1, Joe W Gray1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24804754     DOI: 10.1038/nm.3564

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  Emerging molecular markers of cancer.

Authors:  David Sidransky
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Detection of ultra-rare mutations by next-generation sequencing.

Authors:  Michael W Schmitt; Scott R Kennedy; Jesse J Salk; Edward J Fox; Joseph B Hiatt; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

3.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

4.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Authors:  Aaron M Newman; Scott V Bratman; Jacqueline To; Jacob F Wynne; Neville C W Eclov; Leslie A Modlin; Chih Long Liu; Joel W Neal; Heather A Wakelee; Robert E Merritt; Joseph B Shrager; Billy W Loo; Ash A Alizadeh; Maximilian Diehn
Journal:  Nat Med       Date:  2014-04-06       Impact factor: 53.440

  4 in total
  26 in total

1.  A gold nanoparticle based fluorescent probe for simultaneous recognition of single-stranded DNA and double-stranded DNA.

Authors:  Haiyan Ma; Zongbing Li; Ning Xue; Zhiyuan Cheng; Xiangmin Miao
Journal:  Mikrochim Acta       Date:  2018-01-10       Impact factor: 5.833

Review 2.  Personalized targeted therapy for esophageal squamous cell carcinoma.

Authors:  Xiaozheng Kang; Keneng Chen; Yicheng Li; Jianying Li; Thomas A D'Amico; Xiaoxin Chen
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.

Authors:  Bee Luan Khoo; Gianluca Grenci; Ying Bena Lim; Soo Chin Lee; Jongyoon Han; Chwee Teck Lim
Journal:  Nat Protoc       Date:  2017-12-07       Impact factor: 13.491

4.  Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms.

Authors:  SeungHyun Jeon; HyungJae Lee; Kieun Bae; Kyong-Ah Yoon; Eun Sook Lee; Youngnam Cho
Journal:  Theranostics       Date:  2016-04-11       Impact factor: 11.556

Review 5.  Circulating biomarkers to monitor cancer progression and treatment.

Authors:  Suthee Rapisuwon; Eveline E Vietsch; Anton Wellstein
Journal:  Comput Struct Biotechnol J       Date:  2016-06-01       Impact factor: 7.271

6.  Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.

Authors:  Elena I Pentsova; Ronak H Shah; Jiabin Tang; Adrienne Boire; Daoqi You; Samuel Briggs; Antonio Omuro; Xuling Lin; Martin Fleisher; Christian Grommes; Katherine S Panageas; Fanli Meng; S Duygu Selcuklu; Shahiba Ogilvie; Natalie Distefano; Larisa Shagabayeva; Marc Rosenblum; Lisa M DeAngelis; Agnes Viale; Ingo K Mellinghoff; Michael F Berger
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

7.  The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment.

Authors:  Naoko Sueoka-Aragane; Chiho Nakashima; Hironori Yoshida; Naohisa Matsumoto; Kentaro Iwanaga; Noriyuki Ebi; Akihiro Nishiyama; Kazuhiro Yatera; Shoichi Kuyama; Minoru Fukuda; Sunao Ushijima; Hitomi Umeguchi; Daijiro Harada; Kosuke Kashiwabara; Takayuki Suetsugu; Nobukazu Fujimoto; Fumihiro Tanaka; Hidetaka Uramoto; Chiharu Yoshii; Katsumi Nakatomi; Genju Koh; Nobuhiko Seki; Keisuke Aoe; Kaname Nosaki; Koji Inoue; Ayako Takamori; Atsushi Kawaguchi
Journal:  Cancer Med       Date:  2021-05-12       Impact factor: 4.452

8.  SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.

Authors:  Julia Stadler; Johanna Eder; Barbara Pratscher; Sabine Brandt; Doris Schneller; Robert Müllegger; Claus Vogl; Franz Trautinger; Gottfried Brem; Joerg P Burgstaller
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

Review 9.  Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer.

Authors:  Shiyu Jia; Rui Zhang; Ziyang Li; Jinming Li
Journal:  Oncotarget       Date:  2017-04-18

10.  Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis.

Authors:  Chang Gon Kim; Hyo Sup Shim; Min Hee Hong; Yoon Jin Cha; Su Jin Heo; Hyung Soon Park; Jee Hung Kim; Jin Gu Lee; Chang Young Lee; Byoung Chul Cho; Hye Ryun Kim
Journal:  Oncotarget       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.